Results 71 to 80 of about 2,517,915 (228)

Blockade of 5-Hydroxytryptamine Antidiuresis in Rats by 2-Bromlysergic Acid Diethylamide Tartrate and 1-Methyl-Lysergic Acid Butanolamide

, 1963
The effects of two lysergic acid derivatives, 2-bromlysergic acid diethylamide ‘BOL 148’ and 1-methyl-lysergic acid butanolamide ‘UML 491’ on the antidiuresis induced by 5-hydroxytryptamine ‘5-HT’ has been studied in rats given a dose of 1 mg./kg.
A Chodera
core   +1 more source

Possible role of biochemiluminescent photons for lysergic acid diethylamide (LSD)-induced phosphenes and visual hallucinations [PDF]

, 2021
Today, there is an increased interest in research on lysergic acid diethylamide (LSD) because it may offer new opportunities in psychotherapy under controlled settings.
Bókkon, István, Császár, Noémi, Scholkmann, Felix, Szőke, Henrik, Kapócs, Gábor, Salari, Vahid   +5 more
core  

Evaluation of 1cp-LSD for Enhancing Welfare in Shelter Dogs: A Randomized Blind Trial with Ethological Intervention

Veterinary Sciences
Shelter environments frequently expose dogs to chronic stress and anxiety, which can compromise their welfare and reduce their chances of adoption. Recent interest in psychedelic-assisted approaches has suggested potential therapeutic applications in ...
Elisa Hernández-Álvarez, Cristina Canino-Quijada, Sira Roiz, Octavio P. Luzardo, Luis Alberto Henríquez-Hernández   +4 more
doaj   +1 more source

An ETH‐LAD trip with unfavourable consequences: A case report

British Journal of Clinical Pharmacology, EarlyView.
Numerous analogues of the psychedelic and internationally controlled hallucinogen LSD have been described; however, only a limited number have been systematically investigated. This report presents the first case with an analytically confirmed ingestion of ETH‐LAD (6‐ethyl‐6‐nor‐lysergic acid diethylamide), the N‐ethyl derivative of LSD.
Johannes Nadler, Michaela Sommer, Annette Zschiesche, Anne Stürzebecher, Christina Grumann, Volker Auwärter, Maren Hermanns‐Clausen   +6 more
wiley   +1 more source

Prevalence of novel psychoactive substances in selected clinical urine specimens submitted for drug monitoring

Journal of Forensic Sciences, EarlyView.
Abstract Novel psychoactive substances (NPS) are compounds emerging as alternatives to more established drugs of abuse. They are constantly changing and being modified, which makes their detection difficult. The study objective was to determine the prevalence of NPS in selected clinical specimens. Deidentified urine specimen remnants were analyzed that
Jillian R. Neifeld, Theresa M. Meli, Sarah H. Bartock   +2 more
wiley   +1 more source

sj-pptx-1-jop-10.1177_02698811221104641 – Supplemental material for Effects of acute lysergic acid diethylamide on intermittent ethanol and sucrose drinking and intracranial self-stimulation in C57BL/6 mice

, 2022
Supplemental material, sj-pptx-1-jop-10.1177_02698811221104641 for Effects of acute lysergic acid diethylamide on intermittent ethanol and sucrose drinking and intracranial self-stimulation in C57BL/6 mice by Lauri V Elsilä, Juliana Harkki, Emma Enberg ...
Anni-Maija Linden (206851), Alvar Martti (12876824), Juliana Harkki (12876818), Esa R Korpi (12876827), Lauri V Elsilä (12876815), Emma Enberg (12876821)   +5 more
core   +1 more source

Psychedelic‐assisted treatment for substance use disorder: A narrative systematic review

Addiction, EarlyView.
Abstract Background and aims This is the first systematic review of the extant literature on all major psychedelic‐assisted treatment for alcohol use disorder (AUD), tobacco use disorder (TUD) and other substance use disorders (SUD). We aimed to summarise the evidence for efficacy of psychedelic‐assisted treatment for AUD, TUD, and SUD; to evaluate its
Theodore Piper, Francesca Small, Sam Brown, Michael Kelleher, Luke Mitcheson, James Rucker, Allan H. Young, John Marsden   +7 more
wiley   +1 more source

Lysergic acid diethylamide pretreatment prolongs brain-stimulation induced neural activity changes

Brain Stimulation
A leading theory for how psychedelics are able to produce robust clinical improvement and preclinical behavioral changes is that psychedelics act through neuroplastic mechanisms to induce lasting structural and functional alterations in neural circuits ...
Lucas L. Dwiel, Mackenzi L. Prina, Elise M. Bragg, Matthew Company, Lucky L. Drucker, Laetitia R. Reduron, Bryan W. Luikart, Wilder T. Doucette   +7 more
doaj   +1 more source

5‐Methoxy‐N,N‐dimethyltryptamine (5‐MeO‐DMT) for alcohol use disorder: An open‐label, phase 2, proof‐of‐concept, clinical trial

Addiction, EarlyView.
Abstract Background and Aims Psychedelic drugs may help treat alcohol use disorder (AUD). This study evaluated BPL‐003, a novel intranasal powder formulation of 5‐methoxy‐N,N‐dimethyltryptamine (5‐MeO‐DMT) benzoate salt, in people with moderate–severe AUD enrolled in a standard of care, 10‐week programme of relapse‐prevention oriented Cognitive ...
John Marsden, Michael Kelleher, Fiona Dunbar, Anna O. Ermakova, Luke Mitcheson, Claire Roberts, James J. Rucker, Gemma Scott, Ivan Saeger, Francesca Small, Mathieu Seynaeve   +10 more
wiley   +1 more source

sj-docx-1-jop-10.1177_02698811221099650 – Supplemental material for Adverse experiences resulting in emergency medical treatment seeking following the use of lysergic acid diethylamide (LSD)

, 2022
Supplemental material, sj-docx-1-jop-10.1177_02698811221099650 for Adverse experiences resulting in emergency medical treatment seeking following the use of lysergic acid diethylamide (LSD) by Emma I Kopra, Jason A Ferris, James J Rucker, Benjamin ...
Jason A Ferris (12385796), Benjamin McClure (12855027), Allan H Young (9559350), Emma I Kopra (12385793), Adam R Winstock (5196926), James J Rucker (9908841), Caroline S Copeland (12855030)   +6 more
core   +1 more source